Introductory text
United Kingdom
Commission Decision
of 12 June 2009
appointing a Commission representative to the Management Board of the European Medicines Agency
(2009/461/EC)
THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agencyf1, and in particular Article 65 thereof,
Whereas:
(1)
Pursuant to Article 65 of Regulation (EC) No 726/2004, the Management Board of the European Medicine Agency (hereinafter ‘the Agency’) is to include two representatives of the Commission.
(2)
Due to the expiry on 2 June 2009 of the current mandate of the Commission representative and alternate from the Directorate-General for Enterprise and Industry, it is necessary to appoint a member of the Management Board of the Agency from the Directorate-General for Enterprise and Industry and an alternate who will replace the member in his/her absence and vote on his/her behalf,
HAS DECIDED AS FOLLOWS: